1. Enhancing accrual to chemotherapy trials for patients with early stage triple-negative breast cancer: a survey of physicians and patients
   Carmel Jacobs et al, 2017, Supportive Care in Cancer CrossRef
2. Creating a pragmatic trials program for breast cancer patients: Rethinking Clinical Trials (REaCT)
   Bassam Basulaiman et al, 2019, Breast Cancer Research and Treatment CrossRef
3. Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
   Sixian Liang et al, 2015, Oncotarget CrossRef
4. Randomised feasibility trial to compare three standard of care chemotherapy regimens for early stage triple-negative breast cancer (REaCT-TNBC trial)
   John Hilton et al, 2018, PLOS ONE CrossRef
5. The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics
   Carey K. Anders et al, 2016, American Society of Clinical Oncology Educational Book CrossRef
6. Platinum-based chemotherapy in triple-negative advanced breast cancer
   Cynthia Villarreal-Garza et al, 2014, Breast Cancer Research and Treatment CrossRef